The gold-standard methods for diagnosing Alzheimer’s disease are lumbar punctures and PET brain scans. But these methods can be uncomfortable — not to mention…
Healthy diets seem to neurodegenerative diseases like Alzheimer’s. But new research calls everything we thought we knew about the Mediterranean diet into question. Why…
While scientists don’t know yet what causes Alzheimer’s, beta-amyloid protein plaques remain one of the prime suspects. While many approaches have focused on clearing…
The majority of Alzheimer’s research to date has been conducted in white participants. For example, the first FDA-approved anti-amyloid drug to treat Alzheimer’s, Aduhelm,…
Here’s a theory: Alzheimer’s biomarker beta-amyloid could — rather than killing the brain — actually be trying to defend it. The provocative idea builds on…
When Michele Hall began experiencing alarming memory problems, her doctors initially suggested that she was going through menopause or perhaps experiencing unusual levels of…
Drugmakers Eisai and Biogen just announced the success of their latest Phase 3 trial for the Alzheimer’s anti-amyloid drug lecanemab, setting the stage for…
The pursuit of a cure for Alzheimer’s disease is becoming an increasingly competitive and contentious quest with recent years witnessing several important controversies. In…
Like an aged book, DNA in the brain acquires wear and tear during your lifespan. Earlier this year, researchers from Brigham and Women’s Hospital…
Scientists examine the curious case of a woman with genes for early-onset Alzheimer’s who never developed the disease. In an autopsied brain, they found…
Even though Alzheimer’s may start 20 years before symptoms first appear, there are no non-invasive diagnostics to detect it. An initiative called the Diagnostics…
It may be common knowledge that high-sugar, high-fat junk food (think: fried foods, milkshakes, pastries, cakes and cookies) aren’t good for your waistline, but…
Until a few decades ago, most scientific research and clinical drug trials were done in men. That means that, even though certain differences between…
At this year’s AAIC, the developer of an Alzheimer’s blood test debuts promising data, while the Alzheimer’s Association warns new blood-based biomarkers aren’t quite…
In the midst of a media frenzy around fraud allegations and a key Alzheimer’s drug target, reporter Phil Gutis reflects on his personal experience…